AIV Logo AIV Assistant

Loading...

 Logo Evogene Ltd. - EVGN Open Evogene Ltd. in new tab

1.23
EPS
-1.97
P/B
-3.12
ROE
-0.89
Beta
1.43

1.2300

1.230

Daily: -3.91%
Key Metrics

Earnings date: Nov. 20, 2025

EPS: -1.97

Book Value: -0.41

Price to Book: -3.12

Debt/Equity: 21.49

% Insiders: 0.010%

Growth

Revenue Growth: -0.03%

Estimates

Forward P/E: -0.37

Forward EPS: -3.46

 Logo About Evogene Ltd. - (EVGN)

Country: Israel

Sector: Health Care

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion